Hermes Medical Solutions announces Health Canada approval for latest Hermia software update
Stockholm, Sweden – May 27, 2026 – Hermes Medical Solutions (HMS), a global leader in molecular imaging and dosimetry software solutions, proudly announces that the latest release of its flagship platform Hermia, featuring significant new advancements*, has now been approved by Health Canada, enabling expanded access to these powerful tools across Canadian nuclear medicine and theranostics practices.
“This latest release represents a significant step forward in personalized medicine for oncology and beyond,” says Tom Francke, Chief Executive Officer at Hermes Medical Solutions. “With Health Canada approval now secured, clinicians across Canada can leverage upgraded segmentation tools, automated workflows, and advanced image analysis for faster, more precise quantitation, and personalized dosimetry.”
The updated Hermia release delivers an intuitive, comprehensive toolkit designed to streamline nuclear medicine imaging and dosimetry workflows across multiple modalities, including PET/CT, SPECT/CT, PET/MR, and RTDOSE, and is now authorized for clinical use in Canada.
Key features now accessible under Health Canada approval include:
Hermia SIRT – Enhanced dosimetry for selective internal radiation therapy
Hermia’s SIRT application delivers a streamlined, precise planning and verification workflow aligned with EANM guidelines. Features include CT-based organ segmentation, live dose optimization, multi-target planning, automated 3D lung shunt calculations, and deformable registration for post-therapy assessment.
Hermia Lung Lobe Quantification
This tool facilitates enhanced diagnostic precision by combining CT segmentation of lung lobes with perfusion and ventilation SPECT imaging. With a new segmentation algorithm and advanced registration technology, clinicians can rapidly and accurately delineate lung lobes and visualize 3D-rendered lobe presentations to support procedures such as lung volume reduction.
With Health Canada’s approval, Hermia is now positioned to support Canadian healthcare professionals with a robust, versatile platform that enhances diagnostic confidence and supports personalized patient care.
*May be subject to regulatory clearance in your market.
About Hermes Medical Solutions
Since its establishment in 1976, in Stockholm, Sweden, Hermes Medical Solutions continuously innovates to enable faster and more personalized diagnosis and therapies in molecular imaging. Hermes Medical Solutions was first to develop SPECT reconstruction software and dual-head whole-body scanning and first to introduce medical image fusion software for combined viewing of images from different scanners. With Hermia, we empower healthcare professionals with state-of-the-art software for all clinical scenarios into ONE vendor-neutral software suite. Combining leadership in innovation for NM/MI software with customer-driven service is our mission and our success lies in our close and longstanding collaboration with our customers to meet their software, support, and service needs. The result is improved quality in patient management and decision support for thousands of healthcare providers and their patients worldwide.
www.hermesmedical.com
Contact
Bridget Watson
Chief Marketing Officer
Hermes Medical Solutions AB (HQ)
Strandbergsgatan 16
112 51 Stockholm, Sweden
Tel: +46 76 076 47 28
bridget.watson@hermesmedical.com